healthcare.digital January 10, 2026
Nelson Advisors

Executive Summary

The European healthcare technology (HealthTech) and medical technology (MedTech) landscape enters 2026 at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of “industrial maturity.”

Following a period of post-pandemic recalibration in 2024 and a tentative recovery in 2025, the market is poised for a robust, albeit structurally transformed, resurgence in mergers and acquisitions (M&A). The defining theme for the 2026 vintage is “Industrialisation.”

This concept signifies a departure from the fragmented, venture-subsidised experimentation that characterised the 2019–2022 era, moving instead toward scalable, profit-generating platforms that leverage operational leverage, regulatory fortitude, and vertical integration to dominate their respective sub-sectors.

While headline deal values are projected to rise,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, Medical Devices, Mergers & Acquisitions / JV, Technology, Trends
Freeman Health System acquires Missouri facility to expand outpatient services
5 payer M&A deals | 2026
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

Share Article